P
Pixelgen
Biotech & Life Sciences · Stockholm, Sweden · Founded 2020
Spatial proteomics platform mapping the molecular architecture of individual cells MoreLess
Pixelgen is a Stockholm, Sweden life-sciences company founded in 2020 by Simon Fredriksson, Alvaro Martinez Barrio, Fredrik Dahl and Filip Karlsson. Its Proxiome platform uses DNA-based Molecular Pixelation to map how proteins are organized, clustered and positioned on the surface of single cells, adding spatial architecture to conventional protein-abundance measurements. The company emerged from stealth in 2022 and closed an oversubscribed $15.5 million Series B in August 2026, led by Flat Capital with continued participation from Industrifonden and Navigare Ventures, to commercialize globally. CEO and co-founder Simon Fredriksson previously co-founded Olink and Genagon Therapeutics; other founding expertise includes computational science and product development at 10x Genomics, Halo Genomics and Vanadis.
Talent graph
Pixelgen's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Pixelgen has talent and traffic
team presence
Market sentiment
What the market is saying about Pixelgen
An AI-synthesized read of the highest-engagement posts about Pixelgen on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Pixelgen on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.